COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance

by Suzanne C. Cannegieter, Frederikus A. Klok
Published 2020-05-01

High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?

by Anja J.M. Schreijer, Pieter H. Reitsma, Suzanne C. Cannegieter
Published 2010-02-01

Sex‐specific aspects of venous thromboembolism: What is new and what is next?

by Luuk J. J. Scheres, Astrid vanHylckama Vlieg, Suzanne C. Cannegieter
Published 2022-05-01

Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk

by Suely Meireles Rezende, Willem M. Lijfering, Frits R. Rosendaal, Suzanne C. Cannegieter
Published 2014-01-01

Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors.

by Linda E Flinterman, Astrid van Hylckama Vlieg, Suzanne C Cannegieter, Frits R Rosendaal
Published 2012-01-01

Travel-related venous thrombosis: results from a large population-based case control study (MEGA study).

by Suzanne C Cannegieter, Carine J M Doggen, Hans C van Houwelingen, Frits R Rosendaal
Published 2006-08-01

The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations.

by Saskia Kuipers, Suzanne C Cannegieter, Saskia Middeldorp, Luc Robyn, Harry R Büller, Frits R Rosendaal
Published 2007-09-01

Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study.

by Sverre C Christiansen, Inger Anne Naess, Suzanne C Cannegieter, Jens Hammerstrøm, Frits R Rosendaal, Pieter H Reitsma
Published 2006-08-01

Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations

by Linda Nab, Rolf H. H. Groenwold, Frederikus A. Klok, Soerajja Bhoelan, Marieke J. H. A. Kruip, Suzanne C. Cannegieter
Published 2022-08-01

Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study

by Eng Soo Yap, Willem M. Lijfering, Jasmijn F. Timp, Frits R. Rosendaal, Suzanne C. Cannegieter, Luuk J. J. Scheres
Published 2023-02-01

Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique

by Kirsten van Langevelde, Alexandr Šrámek, Patrice W.J. Vincken, Jan-Kees van Rooden, Frits R. Rosendaal, Suzanne C. Cannegieter
Published 2013-02-01

Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2)

by Petter Quist-Paulsen, Inger Anne Næss, Suzanne C. Cannegieter, Pål R. Romundstad, Sverre C. Christiansen, Frits R. Rosendaal, Jens Hammerstrøm
Published 2010-01-01

Population-based 10-year cumulative revision risks after hip and knee arthroplasty for osteoarthritis to inform patients in clinical practice: a competing risk analysis from the Du...

by Maaike G J Gademan, Liza N Van Steenbergen, Suzanne C Cannegieter, Rob G H H Nelissen, Perla J Marang-Van De Mheen
Published 2021-05-01

Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020

by Eva K. Kempers, Qingui Chen, Chantal Visser, Eric C. M. van Gorp, Frederikus A. Klok, Suzanne C. Cannegieter, Marieke J. H. A. Kruip
Published 2023-08-01

Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy

by Carolina E. Touw, Banne Nemeth, Raymond A. van Adrichem, Astrid van Hylckama Vlieg, Rob G. H. H. Nelissen, Ton Lisman, Suzanne C. Cannegieter
Published 2023-04-01

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism

by Sake J. van der Wall, Frederikus A. Klok, Paul L. den Exter, Deisy Barrios, Raquel Morillo, Suzanne C. Cannegieter, David Jimenez, Menno V. Huisman
Published 2018-02-01

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

by Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter, The Dutch COVID & Thrombosis Coalition
Published 2021-10-01

Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).

by Jasmijn F Timp, Sigrid K Braekkan, Willem M Lijfering, Astrid van Hylckama Vlieg, John-Bjarne Hansen, Frits R Rosendaal, Saskia le Cessie, Suzanne C Cannegieter
Published 2019-10-01

Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).

by Jasmijn F Timp, Sigrid K Braekkan, Willem M Lijfering, Astrid van Hylckama Vlieg, John-Bjarne Hansen, Frits R Rosendaal, Saskia le Cessie, Suzanne C Cannegieter
Published 2021-04-01

Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Cont...

by Banne Nemeth, Raymond A van Adrichem, Astrid van Hylckama Vlieg, Paolo Bucciarelli, Ida Martinelli, Trevor Baglin, Frits R Rosendaal, Saskia le Cessie, Suzanne C Cannegieter
Published 2015-11-01